Le Lézard
Classified in: Health
Subject: PER

Knowledge to Practice Appoints Medical Director to Accelerate Its Clinical Content Expansion


BETHESDA, Md., July 18, 2018 /PRNewswire/ -- Knowledge to Practice (K2P), a leading provider of personalized, competency-based lifelong learning for practicing physicians, hospitals and healthcare systems, announces today the appointment of Chimene Richa, MD, as the Medical Director. In her new role, Dr. Richa will be responsible for leading curriculum design and clinical content strategies across specialty areas and will lead and manage a team of clinical writers, editors and all of our renown contributing faculty from the top academic medical centers.

Chimene Richa, MD

"We are very excited to welcome Dr. Richa, who joins K2P's next stage of growth and expansion of our clinical content," says Mary Ellen Beliveau, Founder and CEO of Knowledge to Practice. "Chimene's wealth of clinical knowledge and academic experience will further K2P's leadership in personalized and adaptive online medical education curricula that is uniquely positioned to improve medical practice and deliver tangible improvements at hospitals and healthcare systems."

Dr. Richa holds a Bachelor of Science degree in Biology from Villanova University (Summa Cum Laude), received her M.D. degree from the University of Pennsylvania School of Medicine, completed her Ophthalmology residency at the University of Maryland, and pursued an Oculoplastics fellowship at Allegheny General Hospital. Prior to joining K2P, Dr. Richa was a Clinical Assistant Professor in the Department of Ophthalmology at University of Maryland School of Medicine and also served as Associate Program Director and Director of Medical Student Education for the Department of Ophthalmology. As the Medical Director for K2P Dr. Richa will continue limited clinical practice in the Department of Ophthalmology at University of Maryland School of Medicine.

"Knowledge to Practice's online medical educational content is industry-leading, and I'm proud to be part of the team," says Dr. Chimene Richa. "I look forward to leading our talented clinical writers and collaborating with expert faculty to develop online content that is high-yield and delivers innovative learning experiences in both evidence-based and emerging medicine."

To learn more about Knowledge to Practice visit https://knowlegetopractice.com

About Knowledge to Practice
Knowledge to Practice delivers practice-changing, healthcare education solutions that help transform patient care, enable continuity of care, and mitigate risks across hospitals and healthcare systems. Knowledge to Practice's personalized curriculum results in an average of 56 percent improvement of knowledge retention and recall, compared to 3-5 percent of older continuing medical education (CME) models. Using best practices and adult learning techniques, Knowledge to Practice taps top recognized academicians and thought leaders to deliver practice-changing clinical content. Curricula are then personalized to each physician, enabling them to monitor their personal mastery and learn wherever, whenever and however they choose. To learn more about Knowledge to Practice please visit: www.KnowledgeToPractice.com.

CONTACT: Matt Chan, Chief Marketing Officer, [email protected], +1 (240) 650-1226

 

Changing Minds, Changing Practice (PRNewsfoto/Knowledge to Practice)

SOURCE Knowledge to Practice


These press releases may also interest you

at 16:10
Acadia Pharmaceuticals Inc. today announced that it will report first quarter financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets. Acadia's management team will also host a conference call and webcast on May 8,...

at 16:10
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, May...

at 16:05
BeiGene, Ltd. , a global oncology company, today announced it will share research outcomes from its broad hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024....

at 16:05
Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafungin...

at 16:05
Arrowhead Pharmaceuticals, Inc. today announced that it will host a webcast and conference call on May 9, 2024, at 4:30 p.m. ET to discuss its financial results for the fiscal second quarter ended March 31, 2024. Webcast and Conference Call and...

at 16:05
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced three accepted abstracts at the 2024 American Society of...



News published on and distributed by: